Which hedge funds own GEHC? GE HEALTHCARE TECHNOLOGIES I, Q2 2026 13F holders
Healthcare · Open on the interactive board
12 of the hedge funds tracked by WhaleCreep disclosed a position in GEHC (GE HEALTHCARE TECHNOLOGIES I) in their Q2 2026 13F filings, worth $478.9m in total. The largest holder by portfolio weight is Trian Fund Management at 4.7% of its book. 1 manager opened a new position this quarter: Holocene Advisors. 5 exited: Anomaly Capital Management, Farallon Capital Management, First Manhattan.
12tracked managers holding
1opened this quarter
5exited this quarter
Which hedge funds hold GEHC? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Trian Fund Management | Q2 2026 | 4.7% | $197.5m | 3,085,344 | 76194% | added |
| Point72 Asset Management LP | Q2 2026 | 0.1% | $74.6m | 1,165,973 | 832% | added |
| Citadel Advisors | Q2 2026 | 0.1% | $151.5m | 2,367,032 | 83% | added |
| Semper Augustus Investments Group | Q2 2026 | 0.0% | $293.2k | 4,581 | 0% | held |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $26.8m | 418,089 | -11% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $18.5m | 289,617 | 70% | added |
| Holocene Advisors | Q2 2026 | 0.0% | $5.0m | 77,507 | – | new |
| Brevan Howard Capital Management | Q2 2026 | 0.0% | $518.2k | 8,096 | 1% | added |
| Woodline Partners | Q2 2026 | 0.0% | $1.7m | 25,987 | 46% | added |
| Bridgewater Associates | Q2 2026 | 0.0% | $998.2k | 15,595 | -78% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $152.0k | 2,375 | -1% | reduced |
| Marshall Wace | Q2 2026 | 0.0% | $1.3m | 20,900 | -88% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Anomaly Capital Management | 19.4% | $61.5m |
| Farallon Capital Management | 0.0% | $213.5k |
| First Manhattan | 0.1% | $344.3k |
| Horizon Kinetics | 0.4% | $207.2k |
| Renaissance Technologies LLC | 0.3% | $18.1m |
How has hedge fund ownership of GEHC changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 12 | $478.9m |
| Q1 2026 | 17 | $248.0m |
| Q4 2025 | 13 | $487.2m |
| Q3 2025 | 12 | $378.0m |
| Q2 2025 | 16 | $705.3m |
| Q1 2025 | 15 | $541.8m |
| Q4 2024 | 18 | $958.4m |
| Q3 2024 | 13 | $1.0bn |
| Q2 2024 | 13 | $911.9m |
| Q1 2024 | 15 | $1.2bn |
| Q4 2023 | 9 | $530.3m |
| Q3 2023 | 8 | $278.9m |
| Q2 2023 | 10 | $474.0m |
| Q1 2023 | 9 | $293.9m |
| Q4 2022 | 1 | $44.1m |
Counts every tracked manager that disclosed GEHC in that quarter's filing, including managers that have since stopped filing.